skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Failure of desferrioxamine to modify the toxicity of paraquat in rats

Journal Article · · J. Free Radi. Biol. Medic.; (United States)

The feasibility of using desferrioxamine (DF), an iron chelator, as a therapeutic agent against paraquat (PQ/sup + +/) toxicity in male Sprague-Dawley rats was explored, based on the rationale of limiting toxic hydroxyl radical production from hydrogen peroxide by removing redox-active iron. Body weights, mortality, and lung histopathology were followed for periods up to 14 days after intraperitoneal injection of PQ/sup + +/ (20 or 25 mg/kg body weight) with or without concurrent daily subcutaneous injections of DF (300 mg/day). Animals receiving PQ/sup + +/ showed the expected typical patterns of mortality and of lung histopathology, namely: marked edema, subpleural hemorrhage, acute inflammation, perivascular mononuclear cell infiltrates, sloughing of alveolar and bronchiolar lining cells, and diffuse interstitial fibrosis. Desferrioxamine alone was non-toxic. Surprisingly, results when both PQ/sup + +/ and DF were administered indicated a failure of DF to ameliorate toxic effects of PQ/sup + +/ in the lung, and even suggested an accentuation of PQ/sup + +/-induced damage by DF. Mortality data showed that PQ/sup + +//DF animals died in greater numbers (20 mg PQ/sup + +//kg) or died earlier (25 mg PQ/sup + +//kg) than animals receiving DF alone. Qualitative histopathology in PQ/sup + +//DF animals was comparable to PQ/sup + +/ animals in early stages, but damage was more severe in both incidence and severity of lesions in PQ/sup + +//DF animals, particularly at the 25 mg PQ/sup + +//kg dose level. After 14 days, surviving animals receiving PQ/sup + +/ alone showed almost complete resolution of previous inflammation and other acute effects, whereas in the only surviving PQ/sup + +//DF animal initial fibrosis had persisted and become more generalized. 51 references, 6 figures, 2 tables.

Research Organization:
Brookhaven National Lab., Upton, NY
DOE Contract Number:
AC02-76CH00016
OSTI ID:
6133494
Journal Information:
J. Free Radi. Biol. Medic.; (United States), Vol. 1
Country of Publication:
United States
Language:
English